JP6988463B2 - Microbial adhesion inhibitor for tooth surface - Google Patents
Microbial adhesion inhibitor for tooth surface Download PDFInfo
- Publication number
- JP6988463B2 JP6988463B2 JP2017249194A JP2017249194A JP6988463B2 JP 6988463 B2 JP6988463 B2 JP 6988463B2 JP 2017249194 A JP2017249194 A JP 2017249194A JP 2017249194 A JP2017249194 A JP 2017249194A JP 6988463 B2 JP6988463 B2 JP 6988463B2
- Authority
- JP
- Japan
- Prior art keywords
- tooth surface
- copolymer
- adhesion inhibitor
- microbial adhesion
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003112 inhibitor Substances 0.000 title claims description 43
- 230000000813 microbial effect Effects 0.000 title description 45
- 229920001577 copolymer Polymers 0.000 claims description 45
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- 239000000080 wetting agent Substances 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- VUQGLVBDEHMYLL-UHFFFAOYSA-N CCOC(C(C)=C)=O.NCC(CO)O Chemical compound CCOC(C(C)=C)=O.NCC(CO)O VUQGLVBDEHMYLL-UHFFFAOYSA-N 0.000 claims description 8
- HMZGPNHSPWNGEP-UHFFFAOYSA-N octadecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(C)=C HMZGPNHSPWNGEP-UHFFFAOYSA-N 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 150000005846 sugar alcohols Polymers 0.000 claims description 4
- 238000000034 method Methods 0.000 description 18
- 239000000243 solution Substances 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 235000002639 sodium chloride Nutrition 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 241000194019 Streptococcus mutans Species 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- 239000000178 monomer Substances 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- -1 n-decyl group Chemical group 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000011230 binding agent Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 230000010065 bacterial adhesion Effects 0.000 description 5
- 238000001641 gel filtration chromatography Methods 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
- 208000002064 Dental Plaque Diseases 0.000 description 4
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 208000002925 dental caries Diseases 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical group OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- 208000028169 periodontal disease Diseases 0.000 description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- JEVGKYBUANQAKG-UHFFFAOYSA-N victoria blue R Chemical compound [Cl-].C12=CC=CC=C2C(=[NH+]CC)C=CC1=C(C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 JEVGKYBUANQAKG-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 description 1
- QEIVBYMCAXDVKE-UHFFFAOYSA-N 1-(ethoxycarbonylamino)ethyl 2-methylprop-2-enoate;propane-1,2,3-triol Chemical compound OCC(O)CO.CCOC(=O)NC(C)OC(=O)C(C)=C QEIVBYMCAXDVKE-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- WYGWHHGCAGTUCH-UHFFFAOYSA-N 2-[(2-cyano-4-methylpentan-2-yl)diazenyl]-2,4-dimethylpentanenitrile Chemical compound CC(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)C WYGWHHGCAGTUCH-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 241000511976 Hoya Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002413 Polyhexanide Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000002253 acid Chemical group 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000007809 chemical reaction catalyst Substances 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004956 cyclohexylene group Chemical group 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- IBUDOENFVGHGFQ-UHFFFAOYSA-N hydroxy propyl carbonate Chemical compound CCCOC(=O)OO IBUDOENFVGHGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 125000005645 linoleyl group Chemical group 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- RBQRWNWVPQDTJJ-UHFFFAOYSA-N methacryloyloxyethyl isocyanate Chemical compound CC(=C)C(=O)OCCN=C=O RBQRWNWVPQDTJJ-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940093158 polyhexanide Drugs 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 239000007870 radical polymerization initiator Substances 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000021148 sequestering of metal ion Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940079841 sodium copper chlorophyllin Drugs 0.000 description 1
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- GEYJUFBPCGDENK-UHFFFAOYSA-M sodium;3,8-dimethyl-5-propan-2-ylazulene-1-sulfonate Chemical compound [Na+].CC(C)C1=CC=C(C)C2=C(S([O-])(=O)=O)C=C(C)C2=C1 GEYJUFBPCGDENK-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
Landscapes
- Dental Preparations (AREA)
Description
本発明は、微生物付着抑制性能に優れる歯面用の微生物付着抑制剤に関する。 The present invention relates to a microbial adhesion inhibitor for tooth surfaces, which has excellent microbial adhesion inhibitory performance.
デンタルプラークは、歯面に付着する微生物と菌体間基質からなる凝集体であり、う蝕や歯周病等の口腔疾患の原因となる。そのため、歯面にデンタルプラークを形成させないことが、う蝕を予防するための対策となる。歯の表面を構成するエナメル質は、その大部分がハイドロキシアパタイトというリン酸カルシウム系の構造からなる。よって、歯の表面は、歯科補綴物で使用される素材と性質が異なり、静電相互作用や水酸基との水素結合相互作用によって、タンパク質、アミノ酸、及び糖等の吸着性が高いことが知られており、デンタルプラークが形成しやすい場所であると考えられている(非特許文献1、2)。 Dental plaque is an aggregate composed of microorganisms adhering to the tooth surface and an intercellular substrate, and causes oral diseases such as dental caries and periodontal disease. Therefore, preventing dental plaque from forming on the tooth surface is a measure to prevent dental caries. Most of the enamel that constitutes the tooth surface has a calcium phosphate-based structure called hydroxyapatite. Therefore, it is known that the tooth surface has different properties from the material used in dental prostheses, and has high adsorptivity for proteins, amino acids, sugars, etc. due to electrostatic interaction and hydrogen bond interaction with hydroxyl groups. It is considered to be a place where dental plaque is likely to form (Non-Patent Documents 1 and 2).
特許文献1には、微生物付着防止成分としてホスホリルコリン基含有重合体を用いると共に、バインダー成分として水溶性多糖類、相溶化成分としてポリ(メタ)アクリル酸誘導体を用いることを特徴とする口腔用微生物付着防止剤が開示されている。 Patent Document 1 is characterized in that a phosphorylcholine group-containing polymer is used as a microorganism adhesion-preventing component, a water-soluble polysaccharide is used as a binder component, and a poly (meth) acrylic acid derivative is used as a compatibilizing component. Inhibitors are disclosed.
特許文献1に記載された口腔用微生物付着防止剤においては、ホスホリルコリン基含有重合体を口腔内に留めるために、バインダー成分として水溶性多糖類、相溶化成分としてポリ(メタ)アクリル酸誘導体を配合する必要があり、必ずしも使用者にとって簡便に使用できるものでなかった。
本発明の課題は、前記従来の問題を鑑みてなされたものであって、バインダー成分を使用することなく歯面に対して微生物付着抑制剤を付着させることができると共に、優れた微生物付着抑制性能を有する歯面用の微生物付着抑制剤を提供することである。
In the oral microbial adhesion inhibitor described in Patent Document 1, a water-soluble polysaccharide is blended as a binder component and a poly (meth) acrylic acid derivative is blended as a compatibilizing component in order to retain the phosphorylcholine group-containing polymer in the oral cavity. It was necessary to do so, and it was not always easy for the user to use.
The subject of the present invention has been made in view of the above-mentioned conventional problems, and it is possible to attach a microbial adhesion inhibitor to the tooth surface without using a binder component, and it has excellent microbial adhesion inhibitory performance. It is to provide the microbial adhesion inhibitor for the tooth surface which has.
本発明者らは、前記従来の課題を解決するために鋭意検討を行った結果、特定の2種の構成単位を有する共重合体を特定量含有する歯面用微生物付着抑制剤であれば、バインダー等を使用することなく歯面に対する微生物の付着を抑制することができることを見出し、本発明を完成するに至った。 As a result of diligent studies to solve the above-mentioned conventional problems, the present inventors have provided a tooth surface microbial adhesion inhibitor containing a specific amount of a copolymer having two specific structural units. We have found that it is possible to suppress the adhesion of microorganisms to the tooth surface without using a binder or the like, and have completed the present invention.
すなわち、本発明は下記[1]〜[4]を要旨とするものである。
[1]下記一般式(1)で表される構成単位、及び下記一般式(2)で表される構成単位を有する共重合体を含み、前記共重合体の含有量が0.003質量%以上1質量%以下である歯面用微生物付着抑制剤。
That is, the gist of the present invention is the following [1] to [4].
[1] A copolymer having a structural unit represented by the following general formula (1) and a structural unit represented by the following general formula (2) is contained, and the content of the copolymer is 0.003% by mass. A microbial adhesion inhibitor for tooth surfaces having a mass of 1% by mass or more.
(一般式(1)において、R1は水素原子又はメチル基を表し、nは1〜4の整数を表す。)
(In the general formula (1), R 1 represents a hydrogen atom or a methyl group, and n represents an integer of 1 to 4).
(一般式(2)において、R2は水素原子又はメチル基を表し、L1は、−C6H4−、−C6H10−、−(C=O)−O−、−(C=O)−NH−、又は−O−(C=O)−から選ばれる2価の基を表し、L2は炭素数10〜22のアルキル基を表す。)
(In the general formula (2), R 2 represents a hydrogen atom or a methyl group, L 1 is, -C 6 H 4 -, - C 6 H 10 -, - (C = O) -O -, - (C = O) -NH- or -O- (C = O) -represents a divalent group, and L 2 represents an alkyl group having 10 to 22 carbon atoms.)
[2]前記共重合体が、(メタクリル酸グリセリルアミドエチル/メタクリル酸ステアリル)コポリマーである、前記[2]に記載の歯面用微生物付着抑制剤。
[3]更に多価アルコールからなる湿潤剤を含有する、前記[1]又は[2]に記載の歯面用微生物付着抑制剤。
[4]前記湿潤剤の含有量が0.01〜50質量%である、前記[3]に記載の歯面用微生物付着抑制剤。
[2] The microbial adhesion inhibitor for tooth surface according to the above [2], wherein the copolymer is a (glycerylamide ethyl methacrylate / stearyl methacrylate) copolymer.
[3] The microbial adhesion inhibitor for tooth surface according to the above [1] or [2], which further contains a wetting agent composed of a polyhydric alcohol.
[4] The microbial adhesion inhibitor for tooth surface according to the above [3], wherein the content of the wetting agent is 0.01 to 50% by mass.
本発明の歯面用微生物付着抑制剤によれば、バインダー成分を使用することなく歯面に対して微生物付着抑制剤を付着させることができると共に、優れた微生物付着抑制性能を有する歯面用の微生物付着抑制剤を提供することができる。 According to the microbial adhesion inhibitor for tooth surface of the present invention, the microbial adhesion inhibitor can be adhered to the tooth surface without using a binder component, and the tooth surface has excellent microbial adhesion inhibitory performance. A microbial adhesion inhibitor can be provided.
以下、本発明を更に詳細に説明する。
なお、本明細書において、「(メタ)アクリレート」とは、「アクリレート又はメタクリレート」を意味し、他の類似用語についても同様である。
また、本明細書において、好ましい数値範囲(例えば、含有量や重量平均分子量の範囲)を段階的に記載した場合、各下限値及び上限値は、それぞれ独立して組み合わせることができる。例えば、「好ましくは10以上、より好ましくは20以上、そして、好ましくは100以下、より好ましくは90以下」という記載において、「好ましい下限値:10」と「より好ましい上限値:90」とを組み合わせて、「10以上90以下」とすることができる。また、例えば、「好ましくは10〜100、より好ましくは20〜90」という記載においても、同様に「10〜90」とすることができる。
Hereinafter, the present invention will be described in more detail.
In addition, in this specification, "(meth) acrylate" means "acrylate or methacrylate", and the same applies to other similar terms.
Further, in the present specification, when a preferable numerical range (for example, a range of content or weight average molecular weight) is described stepwise, each lower limit value and upper limit value can be independently combined. For example, in the description "preferably 10 or more, more preferably 20 or more, and preferably 100 or less, more preferably 90 or less", "preferable lower limit value: 10" and "more preferable upper limit value: 90" are combined. Therefore, it can be set to "10 or more and 90 or less". Further, for example, even in the description of "preferably 10 to 100, more preferably 20 to 90", it can be similarly set to "10 to 90".
[歯面用微生物付着抑制剤]
本発明の歯面用微生物付着抑制剤は、下記一般式(1)で表される構成単位、及び下記一般式(2)で表される構成単位を有する共重合体を含み、前記共重合体の含有量が0.003質量%以上1質量%以下であるものであり、歯面への微生物の付着を効果的に抑制することができることから、使用者のう蝕予防及び歯周病予防が可能になる。
[Microbial adhesion inhibitor for tooth surface]
The microbial adhesion inhibitor for tooth surface of the present invention contains a copolymer having a structural unit represented by the following general formula (1) and a structural unit represented by the following general formula (2), and the copolymer. The content of is 0.003% by mass or more and 1% by mass or less, and the adhesion of microorganisms to the tooth surface can be effectively suppressed. Therefore, it is possible to prevent caries and periodontal disease of the user. It will be possible.
以下、前記共重合体の構成について詳細に説明する。
<一般式(1)で表される構成単位〔構成単位(1)〕>
Hereinafter, the constitution of the copolymer will be described in detail.
<Structural unit represented by the general formula (1) [Structural unit (1)]>
(一般式(1)において、R1は水素原子又はメチル基を表し、nは1〜4の整数を表す。)
(In the general formula (1), R 1 represents a hydrogen atom or a methyl group, and n represents an integer of 1 to 4).
前記一般式(1)において、R1は水素原子又はメチル基を表し、前記共重合体の保存安定性を向上させる観点から、メチル基が好ましい。
また、前記一般式(1)において、nは1〜4の整数を表し、原料の入手容易性の観点から、nは1〜3が好ましく、1〜2がより好ましい。
In the general formula (1), R 1 represents a hydrogen atom or a methyl group, and a methyl group is preferable from the viewpoint of improving the storage stability of the copolymer.
Further, in the general formula (1), n represents an integer of 1 to 4, and from the viewpoint of availability of raw materials, n is preferably 1 to 3 and more preferably 1 to 2.
前記一般式(1)で表される構成単位の原料となる化合物は公知の方法で製造することができる。例えば、グリセリンのアセタール化体とイソシアーネート基を有する(メタ)アクリレートとをウレタン化反応用触媒の存在下、ウレタン化反応させることにより得られる化合物を、加水分解用の触媒の存在下、水含有溶媒中で加水分解する方法等により製造することができる。 The compound as a raw material of the structural unit represented by the general formula (1) can be produced by a known method. For example, a compound obtained by subjecting an acetalized form of glycerin and a (meth) acrylate having an isocyanate group to a urethanization reaction in the presence of a urethanization reaction catalyst is prepared by water in the presence of a hydrolysis catalyst. It can be produced by a method of hydrolysis in a contained solvent or the like.
前記一般式(1)で表される構成単位の原料となる化合物は、下記一般式(1a)で表すことができ、中でも、R1がメチル基でありnが2であるメタクリル酸グリセリルアミドエチル(本明細書では「グリセロール−1−メタクリロイルオキシエチルウレタン」又は「GMU」ともいう)が好ましい。 The compound used as a raw material for the structural unit represented by the general formula (1) can be represented by the following general formula (1a). Among them, glycerylamide ethyl methacrylate in which R 1 is a methyl group and n is 2. (Also referred to herein as "glycerol-1-methacryloyloxyethyl urethane" or "GMU") are preferred.
(一般式(1a)において、R1は水素原子又はメチル基を表し、nは1〜4の整数を表す。)
(In the general formula (1a), R 1 represents a hydrogen atom or a methyl group, and n represents an integer of 1 to 4).
<一般式(2)で表される構成単位〔構成単位(2)〕>
(一般式(2)において、R2は水素原子又はメチル基を表し、L1は、−C6H4−、−C6H10−、−(C=O)−O−、−(C=O)−NH−、又は−O−(C=O)−から選ばれる2価の基を表し、L2は炭素数10〜22のアルキル基を表す。) (In the general formula (2), R 2 represents a hydrogen atom or a methyl group, L 1 is, -C 6 H 4 -, - C 6 H 10 -, - (C = O) -O -, - (C = O) -NH- or -O- (C = O) -represents a divalent group, and L 2 represents an alkyl group having 10 to 22 carbon atoms.)
前記一般式(2)において、R2は水素原子又はメチル基を表し、前記共重合体の保存安定性を向上させる観点から、メチル基が好ましい。
前記一般式(2)において、L1は、−C6H4−〔フェニレン基〕、−C6H10−〔シクロヘキシレン基〕、−(C=O)−O−〔エステル結合〕、−(C=O)−NH−〔アミド結合〕、又は−O−(C=O)−〔オキシカルボニル結合〕から選ばれる2価の基を表し、原料の入手容易性の観点から、−C6H4−〔フェニレン基〕、−(C=O)−O−〔エステル結合〕、又は−(C=O)−NH−〔アミド結合〕が好ましい。
In the general formula (2), R 2 represents a hydrogen atom or a methyl group, and a methyl group is preferable from the viewpoint of improving the storage stability of the copolymer.
In the general formula (2), L 1 is, -C 6 H 4 - [phenylene], -C 6 H 10 - [cyclohexylene group], - (C = O) -O- [ester bond], - Represents a divalent group selected from (C = O) -NH- [amide bond] or -O- (C = O)-[oxycarbonyl bond], and represents -C 6 from the viewpoint of availability of raw materials. H 4 - [phenylene], - (C = O) -O- [ester bond], or - (C = O) -NH- [amide bond] is preferred.
前記一般式(2)において、L2は、炭素数10〜22のアルキル基を表し、具体的には、n−デシル基、ラウリル基、ミリスチル基、パルミチル基、ステアリル基、アラキジル基、ベヘニル基、オレイル基、リノール基、リノレイル基、及びイソステアリル基等が挙げられる。これらの中でも、歯面用微生物付着抑制剤と歯面との親和性を向上させる観点から、炭素数10〜20のアルキル基が好ましく、炭素数12〜18のアルキル基がより好ましく、炭素数18のアルキル基であるステアリル基が更に好ましい。
一般式(2)で表される構成単位の原料となる化合物の具体例としては、(メタ)アクリル酸ラウリル、及び(メタ)アクリル酸ステアリル等を挙げることができ、中でも(メタ)アクリル酸ラウリル、及び(メタ)アクリル酸ステアリルが好ましく、より具体的には、前記共重合体が(メタクリル酸グリセリルアミドエチル/メタクリル酸ステアリル)コポリマーであることが好ましい。
In the general formula (2), L 2 represents an alkyl group having 10 to 22 carbon atoms, and specifically, an n-decyl group, a lauryl group, a myristyl group, a palmityl group, a stearyl group, an arachidyl group, and a behenyl group. , Oleyl group, linole group, linoleyl group, isostearyl group and the like. Among these, an alkyl group having 10 to 20 carbon atoms is preferable, an alkyl group having 12 to 18 carbon atoms is more preferable, and an alkyl group having 18 carbon atoms is more preferable, from the viewpoint of improving the affinity between the tooth surface microbial adhesion inhibitor and the tooth surface. The stearyl group, which is an alkyl group of the above, is more preferable.
Specific examples of the compound as a raw material of the constituent unit represented by the general formula (2) include lauryl (meth) acrylate and stearyl (meth) acrylate, and among them, lauryl (meth) acrylate. , And stearyl (meth) acrylate, and more specifically, the copolymer is preferably a (glycerylamide ethyl methacrylate / stearyl methacrylate) copolymer.
本発明において、前記共重合体は2種以上の構成単位(1)を含んでもよく、2種以上の構成単位(2)を含んでもよい。また、共重合体は、ランダム共重合体、ブロック共重合体等のいずれの構造であってもよく、またこれらの混合物であってもよい。 In the present invention, the copolymer may contain two or more kinds of structural units (1), or may contain two or more kinds of structural units (2). Further, the copolymer may have any structure such as a random copolymer or a block copolymer, or may be a mixture thereof.
<構成単位(1)及び(2)の割合>
前記共重合体中の構成単位(1)及び構成単位(2)の合計に対する構成単位(1)の含有量は、20モル%以上が好ましく、30モル%以上がより好ましく、40モル%以上がより更に好ましく、50モル%以上がより更に好ましく、そして、90モル%以下が好ましく、80モル%以下がより好ましく、75モル%以下がより好ましく、70モル%以下が更に好ましい。
<Ratio of constituent units (1) and (2)>
The content of the structural unit (1) with respect to the total of the structural unit (1) and the structural unit (2) in the copolymer is preferably 20 mol% or more, more preferably 30 mol% or more, and 40 mol% or more. Even more preferably, 50 mol% or more is further preferable, 90 mol% or less is preferable, 80 mol% or less is more preferable, 75 mol% or less is more preferable, and 70 mol% or less is further preferable.
<その他の構成単位>
本発明に用いる共重合体は、本発明の効果を損なわない範囲において、構成単位(1)及び構成単位(2)以外のその他の構成単位を含んでいてもよいが、前記構成単位(1)及び構成単位(2)のみからなることが好ましい。
前記その他の構成単位は、例えば、前記一般式(1)及び(2)で表される構成単位の原料となる化合物以外の直鎖又は分岐鎖のアルキル(メタ)アクリレート、環状アルキル(メタ)アクリレート、芳香族基含有(メタ)アクリレート、スチレン系単量体、ビニルエーテル単量体、ビニルエステル単量体、親水性の水酸基含有(メタ)アクリレート、酸基含有単量体、窒素含有基含有単量体、アミノ基含有単量体、及びカチオン性基含有単量体から選ばれる重合性単量体に由来する構成単位が挙げられる。
<Other building blocks>
The copolymer used in the present invention may contain other structural units other than the structural unit (1) and the structural unit (2) as long as the effects of the present invention are not impaired. And, it is preferable that it consists only of the structural unit (2).
The other structural unit is, for example, a linear or branched alkyl (meth) acrylate or cyclic alkyl (meth) acrylate other than the compound that is the raw material of the structural unit represented by the general formulas (1) and (2). , Aromatic group-containing (meth) acrylate, styrene-based monomer, vinyl ether monomer, vinyl ester monomer, hydrophilic hydroxyl group-containing (meth) acrylate, acid group-containing monomer, nitrogen-containing group-containing single amount Examples thereof include a structural unit derived from a polymerizable monomer selected from a body, an amino group-containing monomer, and a cationic group-containing monomer.
共重合体がその他の構成単位を含有する場合、全構成単位中のその他の構成単位の割合は、30モル%以下が好ましく、20モル%以下がより好ましく、10モル%以下が更に好ましい。すなわち、全構成単位中の前記構成単位(1)及び構成単位(2)の割合は、70モル%以上が好ましく、80モル%以上がより好ましく、90モル%以上が更に好ましい。 When the copolymer contains other structural units, the ratio of the other structural units to the total structural units is preferably 30 mol% or less, more preferably 20 mol% or less, still more preferably 10 mol% or less. That is, the ratio of the structural unit (1) and the structural unit (2) to all the structural units is preferably 70 mol% or more, more preferably 80 mol% or more, still more preferably 90 mol% or more.
<共重合体の重量平均分子量>
共重合体の重量平均分子量(Mw)は20,000〜90,000が好ましい。共重合体の重量平均分子量が前記下限値以上であると、微生物付着抑制性能が向上し、前記上限値以下であると、共重合体の取り扱い性が向上する。重量平均分子量は40,000〜60,000がより好ましい。
共重合体の重量平均分子量は、ゲルろ過クロマトグラフィー(GFC)分析によるポリエチレングリコール換算の重量平均分子量を指し、GFC分析は、例えば、高速液体クロマトグラフィーシステムCCP&8020シリーズ(東ソー株式会社製)を用いて測定することができる。
<Weight average molecular weight of copolymer>
The weight average molecular weight (Mw) of the copolymer is preferably 20,000 to 90,000. When the weight average molecular weight of the copolymer is at least the lower limit value, the microbial adhesion suppressing performance is improved, and when it is at least the upper limit value, the handleability of the copolymer is improved. The weight average molecular weight is more preferably 40,000 to 60,000.
The weight average molecular weight of the copolymer refers to the weight average molecular weight in terms of polyethylene glycol by gel filtration chromatography (GFC) analysis, and the GFC analysis is performed using, for example, a high performance liquid chromatography system CCP & 8020 series (manufactured by Tosoh Corporation). Can be measured.
<歯面用微生物付着抑制剤中の共重合体の量>
本発明の歯面用微生物付着抑制剤中の共重合体の量は、0.003質量%以上、1質量%以下である。前記共重合体の量が前記下限値未満であると微生物の付着抑制効果を得ることができず、前記共重合体の量が前記上限値を超えて使用しても添加量に見合った効果が得られにくくなる。前記観点から、歯面用微生物付着抑制剤中の共重合体の量は、好ましくは0.004質量%以上、より好ましくは0.005質量%以上であり、そして、好ましくは0.5質量%以下、より好ましくは0.1質量%以下、更に好ましくは0.05質量%以下である。
<Amount of copolymer in microbial adhesion inhibitor for tooth surface>
The amount of the copolymer in the microbial adhesion inhibitor for tooth surface of the present invention is 0.003% by mass or more and 1% by mass or less. If the amount of the copolymer is less than the lower limit, the effect of suppressing the adhesion of microorganisms cannot be obtained, and even if the amount of the copolymer exceeds the upper limit, the effect commensurate with the addition amount can be obtained. It becomes difficult to obtain. From the above viewpoint, the amount of the copolymer in the tooth surface microbial adhesion inhibitor is preferably 0.004% by mass or more, more preferably 0.005% by mass or more, and preferably 0.5% by mass. Hereinafter, it is more preferably 0.1% by mass or less, still more preferably 0.05% by mass or less.
<共重合体の製造方法>
本発明に用いる前記共重合体は、一般的な共重合体の製造方法により製造することができる。例えば、溶媒に前記一般式(1)及び一般式(2)で表される構成単位の原料となる化合物を溶解し、ラジカル重合開始剤の存在下、ラジカル重合で重合させることにより製造することができる。
溶媒としては、例えば、メタノール、エタノール、及びプロパノール等の低級アルコールが挙げられる。
また、重合開始剤としては、例えば、2,2’−アゾビスイソブチロニトリル、2,2’−アゾビス(2,4−ジメチル−バレロニトリル)、過酸化ベンゾイル、及びn−プロピルパーオキシカーボネート等のアゾ系開始剤や、過酸化物系開始剤等の公知の開始剤を使用することができる。
重合温度については特に制限はないが、0℃〜80℃が好ましい。
<Method for producing copolymer>
The copolymer used in the present invention can be produced by a general method for producing a copolymer. For example, it can be produced by dissolving a compound as a raw material of a structural unit represented by the general formula (1) and the general formula (2) in a solvent and polymerizing by radical polymerization in the presence of a radical polymerization initiator. can.
Examples of the solvent include lower alcohols such as methanol, ethanol, and propanol.
Examples of the polymerization initiator include 2,2'-azobisisobutyronitrile, 2,2'-azobis (2,4-dimethyl-valeronitrile), benzoyl peroxide, and n-propylperoxycarbonate. An azo-based initiator such as, or a known initiator such as a peroxide-based initiator can be used.
The polymerization temperature is not particularly limited, but is preferably 0 ° C to 80 ° C.
<任意成分>
本発明の歯面用微生物付着抑制剤は、必要に応じて口腔用組成物に使用できる薬剤、緩衝剤、湿潤剤、界面活性剤、甘味剤、粘稠化剤、溶剤、色材、有機酸、無機塩類、酸化防止剤、安定剤、防腐剤、金属イオン封鎖剤、香料、矯味剤、清涼化剤、及び色素等を含有してもよい。
<Arbitrary ingredient>
The microbial adhesion inhibitor for tooth surface of the present invention is an agent, a buffer, a wetting agent, a surfactant, a sweetener, a thickening agent, a solvent, a coloring material, and an organic acid that can be used in an oral composition as needed. , Inorganic salts, antioxidants, stabilizers, preservatives, metal ion sequestering agents, fragrances, flavoring agents, cooling agents, pigments and the like.
本発明の歯面用微生物付着抑制剤は、特に、湿潤剤を含むことが好ましい。前記共重合体と湿潤剤とを組み合わせて使用することで、微生物付着抑制性能が向上する。
湿潤剤としては多価アルコールが好ましく、多価アルコールとしては、グリセリン、プロピレングリコール、1,3−ブチレングリコール、ペンチレングリコール、ジプロピレングリコール、ポリエチレングリコール、キシリトール、マンニトール、及びエリスリトール等が挙げられる。
歯面用微生物付着抑制剤が湿潤剤を含有する場合、その含有量は0.01〜50質量%が好ましく、0.01〜30質量%がより好ましく、0.01〜20質量%が更に好ましく、1〜12質量%がより更に好ましい。湿潤剤の含有量が前記範囲内であると、微生物付着抑制性能がより向上する。
The microbial adhesion inhibitor for tooth surface of the present invention preferably contains a wetting agent. By using the copolymer in combination with a wetting agent, the microbial adhesion suppressing performance is improved.
The wetting agent is preferably a polyhydric alcohol, and examples of the polyhydric alcohol include glycerin, propylene glycol, 1,3-butylene glycol, pentylene glycol, dipropylene glycol, polyethylene glycol, xylitol, mannitol, and erythritol.
When the microbial adhesion inhibitor for tooth surface contains a wetting agent, the content thereof is preferably 0.01 to 50% by mass, more preferably 0.01 to 30% by mass, still more preferably 0.01 to 20% by mass. , 1-12% by mass is even more preferable. When the content of the wetting agent is within the above range, the microbial adhesion suppressing performance is further improved.
前記薬剤としては、イソプロピルメチルフェノール、塩化デカリウム、塩化ベンザルコニウム、塩化ベンゼトニウム、塩酸アルキルジアミノエチルグリシン、塩酸クロルヘキシジン、グルコン酸クロルヘキシジン、トリクロサン、及び1,8−シネオール等の殺菌剤;
アズレンスルホン酸ナトリウム、アラントイン、グリチルリチン酸及びその塩、及びβ−グリチルレチン酸等の抗炎症剤;
アスコルビン酸及びその塩、塩酸ピリドキシン、酢酸dl−α−トコフェロール、及びニコチン酸dl−α−トコフェロール等のビタミン剤;
イプシロン−アミノカプロン酸、及びトラネキサム酸等の止血剤;
硝酸カリウム、及び乳酸アルミニウム等の知覚過敏緩和剤;
1,8−シネオール等の去痰剤;ゼオライト等の吸着剤;
ピロリン酸二水素二ナトリウム、ピロリン酸ナトリウム、及び塩化亜鉛等の歯石沈着防止剤;
フッ化ナトリウム、及びモノフルオロリン酸ナトリウム等の虫歯予防剤;
銅クロロフィリンナトリウム等の口臭除去剤;
ポリオキシエチレンラウリルエーテル(8〜10E.O.)、及びラウロイルサルコシンナトリウム等の洗浄剤;
塩化ナトリウム、及びl−メントール等の収斂剤;
リン酸一水素ナトリウム、リン酸三ナトリウム、ポリエチレングリコール、及びポリビニルピロリドン等の歯垢除去剤;等が挙げられる。
Examples of the drug include bactericides such as isopropylmethylphenol, depotassium chloride, benzalkonium chloride, benzethonium chloride, alkyldiaminoethylglycine hydrochloride, chlorhexidine hydrochloride, chlorhexidine gluconate, triclosan, and 1,8-cineole;
Anti-inflammatory agents such as sodium azulene sulfonate, allantoin, glycyrrhizic acid and its salts, and β-glycyrrhetinic acid;
Vitamin preparations such as ascorbic acid and its salts, pyridoxine hydrochloride, dl-α-tocopherol acetate, and dl-α-tocopherol nicotinate;
Hemostatic agents such as epsilon-aminocaproic acid and tranexamic acid;
Hypersensitivity relievers such as potassium nitrate and aluminum lactate;
Spouts such as 1,8-cineole; adsorbents such as zeolite;
Anti-tartar agents such as disodium dihydrogen pyrophosphate, sodium pyrophosphate, and zinc chloride;
Caries preventive agents such as sodium fluoride and sodium monofluorophosphate;
Halitosis remover such as sodium copper chlorophyllin;
Detergents such as polyoxyethylene lauryl ether (8-10EO) and sodium lauroyl sarcosine;
Astringents such as sodium chloride and l-menthol;
Dental plaque removers such as sodium monohydrogen phosphate, trisodium phosphate, polyethylene glycol, and polyvinylpyrrolidone; and the like.
緩衝剤としては、クエン酸、リン酸、リンゴ酸、グルコン酸、及びこれらの塩が挙げられ、歯面用微生物付着抑制剤が緩衝剤を含有する場合、その含有量は0.01質量%〜3質量%が好ましい。 Examples of the buffering agent include citric acid, phosphoric acid, malic acid, gluconic acid, and salts thereof. When the tooth surface microbial adhesion inhibitor contains a buffering agent, the content thereof is 0.01% by mass or more. 3% by mass is preferable.
界面活性剤としては、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビタン脂肪酸エステル、ポリグリセリン脂肪酸エステル、アシルアミノ酸塩、脂肪酸アミドプロピルベタイン、及び脂肪酸アミドベタイン等が挙げられる。 Examples of the surfactant include polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid ester, polyglycerin fatty acid ester, acyl amino acid salt, fatty acid amide propyl betaine, fatty acid amide betaine and the like.
防腐剤としては、塩酸ポリヘキサニド、安息香酸、安息香酸塩、及びパラベン類等が挙げられ、歯面用微生物付着抑制剤が防腐剤を含む場合、その含有量は0.01〜5質量%が好ましい。
甘味剤としては、サッカリン、ステビオシド、スクラロース、アスパルテーム、アセスルファムカリウム、及び甘草抽出物が挙げられる。
Examples of the preservative include polyhexanide hydrochloride, benzoic acid, benzoate, parabens and the like, and when the tooth surface microbial adhesion inhibitor contains a preservative, the content thereof is preferably 0.01 to 5% by mass. ..
Sweeteners include saccharin, stevioside, sucralose, aspartame, acesulfame potassium, and licorice extract.
粘稠化剤としては、特に限定されないが、メチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、及びカルボキシメチルセルロース等のセルロース系粘稠化剤、ヒアルロン酸及びその塩、コンドロイチン硫酸及びその塩、アルギン酸及びその塩、ジェランガム、及びキサンタンガム等の多糖類等が挙げられる。 The thickening agent is not particularly limited, but is a cellulosic thickening agent such as methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, and carboxymethyl cellulose, hypromellose and its salt, chondroitin sulfate and its salt, and alginic acid. And its salts, polysaccharides such as gellan gum, xanthan gum and the like.
本発明の歯面用微生物付着抑制剤は、歯面のコーティング剤として使用することで歯面への微生物の付着を抑制することができるが、歯面へのコーティングにあたっては前記共重合体を溶剤に溶解又は懸濁させて使用することが好ましい。
溶剤としては、水、エタノール等の歯科用途に使用されるものであれば特に制限されないが、水が好ましい。
また溶剤は、pHの調整、及び防腐等の目的で塩、界面活性剤、及び防腐剤等を含有してもよい。
本発明の歯面用微生物付着抑制剤が溶剤を含む場合、その含有量は50質量%以上が好ましく、80質量%以上がより好ましく、90質量%以上がより更に好ましい。
The microbial adhesion inhibitor for tooth surface of the present invention can suppress the adhesion of microorganisms to the tooth surface by using it as a coating agent for the tooth surface. However, when coating the tooth surface, the copolymer is used as a solvent. It is preferable to use it by dissolving or suspending it in.
The solvent is not particularly limited as long as it is used for dental purposes such as water and ethanol, but water is preferable.
Further, the solvent may contain a salt, a surfactant, an antiseptic and the like for the purpose of adjusting the pH and preservatives.
When the microbial adhesion inhibitor for tooth surface of the present invention contains a solvent, the content thereof is preferably 50% by mass or more, more preferably 80% by mass or more, still more preferably 90% by mass or more.
<歯面用微生物付着抑制剤の製造方法>
本発明の歯面用微生物付着抑制剤の製造方法に特に制限はなく、前記共重合体を水等の溶媒に混合して撹拌することにより製造することができる。具体的には、60〜90℃程度に加熱した精製水に対して、前記共重合体を撹拌する方法により製造することができ、また、グリセリンや1,3−ブチレングリコール等の任意成分の溶液に対して前記共重合体を投入し、60〜90℃程度で撹拌し、室温まで冷却した後、この溶液に対して精製水を添加して撹拌することにより製造することもできる。
<Manufacturing method of microbial adhesion inhibitor for tooth surface>
The method for producing the microbial adhesion inhibitor for tooth surface of the present invention is not particularly limited, and the copolymer can be produced by mixing the copolymer with a solvent such as water and stirring the mixture. Specifically, it can be produced by a method of stirring the copolymer with purified water heated to about 60 to 90 ° C., and a solution of an arbitrary component such as glycerin or 1,3-butylene glycol. It can also be produced by adding the above-mentioned copolymer to the solution, stirring at about 60 to 90 ° C., cooling to room temperature, and then adding purified water to this solution and stirring.
<歯面用微生物付着抑制剤の使用時の態様>
本発明の歯面用微生物付着抑制剤の使用時の態様に特に制限はないが、口腔保湿剤、洗口液、含嗽剤、歯磨き剤、口中清涼剤、チュアブル剤、及び義歯洗浄剤等として用いることができ、液状、粘性液体、ジェル状、及び錠剤等の形態として用いることができる。
<Aspects when using a microbial adhesion inhibitor for tooth surface>
The mode of use of the microbial adhesion inhibitor for tooth surface of the present invention is not particularly limited, but it is used as an oral moisturizing agent, a mouthwash, a mouthwash, a dentifrice, a mouth refreshing agent, a chewable agent, a denture cleaning agent and the like. It can be used in the form of liquids, viscous liquids, gels, tablets and the like.
以下、本発明を実施例により更に詳細に説明するが、本発明はこれらに限定されない。
<合成例:(メタクリル酸グリセリルアミドエチル/メタクリル酸ステアリル)コポリマーの合成>
4口フラスコに、(R,S)−1,2−イソプロピリデングリセロール330g及びピリジン50mlを加え、滴下ロート及びカルシウム管を装着した。この溶液に対して、室温、遮光下で2−メタクリロイルオキシエチルイソシアネート368g(昭和電工株式会社製)をゆっくりと滴下した。その後、50℃に設定したオイルバス中で7時間反応させた。
反応終了後、ピリジン及び過剰の(R,S)−1,2−イソプロピリデングリセロールを減圧留去することにより、収量621g、収率91%で白色固体の(R,S)−1,2−イソプロピリデングリセロール−3−メタクリロイルオキシエチルウレタンを得た。
Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited thereto.
<Synthesis example: Synthesis of (glycerylamide ethyl methacrylate / stearyl methacrylate) copolymer>
330 g of (R, S) -1,2-isopropyrideneglycerol and 50 ml of pyridine were added to the 4-necked flask, and a dropping funnel and a calcium tube were attached. To this solution, 368 g of 2-methacryloyloxyethyl isocyanate (manufactured by Showa Denko KK) was slowly added dropwise at room temperature and in the dark. Then, the reaction was carried out in an oil bath set at 50 ° C. for 7 hours.
After completion of the reaction, pyridine and excess (R, S) -1,2-isopropyrideneglycerol were distilled off under reduced pressure to obtain a yield of 621 g and a yield of 91% as a white solid (R, S) -1,2-. Isopropyrideneglycerol-3-methacryloyloxyethyl urethane was obtained.
得られた(R,S)−1,2−イソプロピリデングリセロール−3−メタクリロイルオキシエチルウレタン500gに、メタノール1.95L及び4Nの塩酸50mlを加え、室温下30分間攪拌することにより反応させたところ、懸濁液が透明溶液となった。更に60分間攪拌することにより反応させた後、減圧乾燥により溶媒を留去し、無色粘性液体のグリセロール−1−メタクリロイルオキシエチルウレタン(以下、「GMU」ともいう)を得た。収量は412g、収率は96%であった。 To 500 g of the obtained (R, S) -1,2-isopropyrideneglycerol-3-methacryloyloxyethyl urethane, 1.95 L of methanol and 50 ml of 4N hydrochloric acid were added, and the mixture was reacted by stirring at room temperature for 30 minutes. , The suspension became a clear solution. After further reacting by stirring for 60 minutes, the solvent was distilled off by drying under reduced pressure to obtain a colorless viscous liquid glycerol-1-methacryloyloxyethyl urethane (hereinafter, also referred to as “GMU”). The yield was 412 g and the yield was 96%.
前記GMU8.9g(約0.036mol)と、共重合させるモノマーとしてのステアリルメタクリレート(以下、「SMA」ともいう)8.0g(約0.024mol)とをエタノール140gに溶解して、4つ口フラスコに入れた。次いで、得られた溶液に30分間窒素を吹き込んだ後に、60℃で2,2’−アゾビスイソブチロニトリル0.12gを加えて8時間重合反応させた。重合液を3Lのジエチルエーテル中にかき混ぜながら滴下し、析出した沈殿を濾過し、48時間室温で真空乾燥を行うことにより(メタクリル酸グリセリルアミドエチル/メタクリル酸ステアリル)コポリマーを得た。
なお、前記共重合体中の構成単位(1)及び構成単位(2)の合計に対する構成単位(1)の含有量、すなわち、GMUに由来する構成単位とSMAに由来する構成単位の合計に対するGMUに由来する構成単位の量は60モル%であり、ゲルろ過クロマトグラフィー(GFC)分析によるポリエチレングリコール換算の重量平均分子量は50,000であった。
8.9 g (about 0.036 mol) of the GMU and 8.0 g (about 0.024 mol) of stearyl methacrylate (hereinafter, also referred to as “SMA”) as a monomer to be copolymerized are dissolved in 140 g of ethanol, and four flasks are used. Placed in a flask. Then, after blowing nitrogen into the obtained solution for 30 minutes, 0.12 g of 2,2'-azobisisobutyronitrile was added at 60 ° C. and the polymerization reaction was carried out for 8 hours. The polymerization solution was added dropwise to 3 L of diethyl ether with stirring, the precipitated precipitate was filtered, and vacuum dried at room temperature for 48 hours to obtain a (glycerylamide ethyl methacrylate / stearyl methacrylate) copolymer.
The content of the structural unit (1) with respect to the total of the structural units (1) and the structural units (2) in the copolymer, that is, the GMU with respect to the total of the structural units derived from GMU and the structural units derived from SMA. The amount of the structural unit derived from was 60 mol%, and the weight average molecular weight in terms of polyethylene glycol by gel filtration chromatography (GFC) analysis was 50,000.
<実施例1>
80℃に加熱した精製水99.995g中に、前記合成例で製造した(メタクリル酸グリセリルアミドエチル/メタクリル酸ステアリル)コポリマー0.005gを添加し、撹拌することにより実施例1の歯面用微生物付着抑制剤を調製した。
<Example 1>
To 99.995 g of purified water heated to 80 ° C., 0.005 g of the (glycerylamide ethyl methacrylate / stearyl methacrylate) copolymer produced in the above synthesis example was added, and the mixture was stirred to prepare the microorganism for the tooth surface of Example 1. An adhesion inhibitor was prepared.
<比較例1>
配合成分の組成を表1に示すものに変更したこと以外は、実施例1に記載の方法に準じて、比較例1の歯面用微生物付着抑制剤を調製した。
<Comparative Example 1>
A microbial adhesion inhibitor for the tooth surface of Comparative Example 1 was prepared according to the method described in Example 1 except that the composition of the compounding ingredients was changed to that shown in Table 1.
<実施例2>
グリセリン4.75gと1,3−ブチレングリコール4.75gとの混和溶液に対して、(メタクリル酸グリセリルアミドエチル/メタクリル酸ステアリル)コポリマー0.025gを投入し、80℃で撹拌することにより溶解した。溶解後、室温まで冷却した後、前記混和液に対して全量が100gになるように精製水を添加し、撹拌することにより実施例2の歯面用微生物付着抑制剤を調製した。
<Example 2>
0.025 g of the (glycerylamide ethyl methacrylate / stearyl methacrylate) copolymer was added to a mixed solution of 4.75 g of glycerin and 4.75 g of 1,3-butylene glycol, and the mixture was dissolved by stirring at 80 ° C. .. After dissolution, after cooling to room temperature, purified water was added to the admixture so that the total amount was 100 g, and the mixture was stirred to prepare the microbial adhesion inhibitor for tooth surface of Example 2.
<実施例3及び比較例2>
配合成分の組成を表1に示すものに変更したこと以外は、実施例2に記載の方法に準じて、実施例3及び比較例2の歯面用微生物付着抑制剤を調製した。
<Example 3 and Comparative Example 2>
The tooth surface microbial adhesion inhibitor of Example 3 and Comparative Example 2 was prepared according to the method described in Example 2, except that the composition of the compounding component was changed to that shown in Table 1.
<比較例3>
グリセリン4.75gと1,3−ブチレングリコール4.75gとの混和溶液を80℃で攪拌し、室温まで冷却した後、前記混和液に対して全量が100gになるように精製水を添加し、撹拌することにより比較例3の歯面用微生物付着抑制剤を調製した。
<Comparative Example 3>
A mixed solution of 4.75 g of glycerin and 4.75 g of 1,3-butylene glycol was stirred at 80 ° C., cooled to room temperature, and then purified water was added to the mixed solution so that the total amount became 100 g. By stirring, the microbial adhesion inhibitor for the tooth surface of Comparative Example 3 was prepared.
前述の方法により得られた実施例1〜3、及び比較例1〜3の歯面用微生物付着抑制剤について、下記菌付着抑制評価を行った。結果を表1に示す。 The following bacterial adhesion suppression evaluations were performed on the tooth surface microbial adhesion inhibitores of Examples 1 to 3 and Comparative Examples 1 to 3 obtained by the above-mentioned method. The results are shown in Table 1.
<菌付着抑制評価>
(手順1)Streptococcus mutans NBRC13955(以下、「S.mutans」ともいう)をブレインハートインフュージョン培地(ベクトン・ディッキンソン社製)に植菌し、一晩培養した。
(手順2)培養したS.mutans液を遠心分離し、リン酸緩衝液で洗浄した。
(手順3)S.mutans液の光学濃度(660nm)が1.0になるようにリン酸緩衝液で調製した。
(手順4)24ウェルマイクロプレートに実施例1〜3および比較例1〜3の組成物を1mLずつ添加し、それぞれに歯のモデル化合物としてハイドロキシアパタイトのペレット(CELLYARD pellt D5-T2、HOYA(株)製、以下「HAp板」ともいう)を入れ、30秒間静置した。
また、別に精製水1mLに前記HAp板を入れ、1分間静置した。これをコントロールとした。
<Evaluation of bacterial adhesion suppression>
(Procedure 1) Streptococcus mutans NBRC13955 (hereinafter, also referred to as “S. mutans”) was inoculated into Brainheart infusion medium (manufactured by Becton Dickinson) and cultured overnight.
(Procedure 2) The cultured S. mutans solution was centrifuged and washed with a phosphate buffer solution.
(Procedure 3) The S. mutans solution was prepared with a phosphate buffer solution so that the optical concentration (660 nm) was 1.0.
(Procedure 4) 1 mL each of the compositions of Examples 1 to 3 and Comparative Examples 1 to 3 was added to a 24-well microplate, and hydroxyapatite pellets (CELLYARD pellt D5-T2, HOYA Corporation) were added to each as a tooth model compound. ), Hereinafter also referred to as "HAp plate"), and allowed to stand for 30 seconds.
Further, the HAp plate was separately placed in 1 mL of purified water and allowed to stand for 1 minute. This was used as a control.
(手順5)各組成物を取り除き、HAp板を1mLのリン酸緩衝液で3回洗浄した。
(手順6)HAp板の入った24ウェルマイクロプレートに手順3で調製したS.mutans液を0.5mLずつ加え、5時間培養し、HAp板にS.mutansを付着させた。
(手順7)S.mutans液を取り除き、HAp板を1mLのリン酸緩衝液で3回洗浄した。
(手順8)HAp板の入った24ウェルマイクロプレートにビクトリアブルー液を0.5mLずつ加え、10分間静置し、S.mutansを染色した。
(手順9)ビクトリアブルー液を取り除き、HAp板を0.5mLの脱色液で2回洗浄した。
(Procedure 5) Each composition was removed, and the HAp plate was washed 3 times with 1 mL of phosphate buffer.
(Procedure 6) 0.5 mL each of the S. mutans solution prepared in step 3 was added to a 24-well microplate containing a HAp plate, and the cells were cultured for 5 hours to attach S. mutans to the HAp plate.
(Procedure 7) The S. mutans solution was removed, and the HAp plate was washed 3 times with 1 mL of phosphate buffer.
(Procedure 8) 0.5 mL of Victoria Blue solution was added to a 24-well microplate containing a HAp plate, and the mixture was allowed to stand for 10 minutes to stain S. mutans.
(Procedure 9) The Victoria blue solution was removed, and the HAp plate was washed twice with 0.5 mL of decolorizing solution.
(手順10)HAp板を1mLのリン酸緩衝液で3回洗浄した。
(手順11)HAp板の入った24ウェルマイクロプレートにエタノール0.5mLを加え、S.mutansに取り込まれたビクトリアブルー液を抽出した。
(手順12)抽出したビクトリアブルー液を0.1mL量り取り、マイクロプレートリーダー(型式:SpectraMax M3、モレキュラーデバイスジャパン社製)を用いて、595nmにおける吸光度を測定した。
(Procedure 10) The HAp plate was washed 3 times with 1 mL of phosphate buffer.
(Procedure 11) 0.5 mL of ethanol was added to a 24-well microplate containing a HAp plate, and the Victoria blue solution incorporated in S. mutans was extracted.
(Procedure 12) 0.1 mL of the extracted Victoria Blue solution was weighed, and the absorbance at 595 nm was measured using a microplate reader (model: SpectraMax M3, manufactured by Molecular Device Japan Co., Ltd.).
菌付着抑制率を以下の式より算出した。
菌付着抑制率(%)=(Ac−As)/Ac×100
Ac:コントロール(精製水)で処理したHAp板から得られた吸光度
As:実施例及び比較例で処理したHAp板から得られた吸光度
なお、本評価においては、付着した菌の量が多い程、吸光度が高くなる。よって、吸光度が低いほど、歯面用微生物付着抑制剤が菌付着抑制性能に優れていることを示す。
評価結果を表1に示す。
The bacterial adhesion suppression rate was calculated from the following formula.
Bacterial adhesion inhibition rate (%) = (A c -A s) / A c × 100
A c: control (purified water) absorbance obtained from the treated HAp plate in A s: Examples and the absorption measured from HAp plate treated with Comparative Example In the present evaluation, the large amount of attached bacteria The higher the absorbance. Therefore, the lower the absorbance, the better the microbial adhesion inhibitor for the tooth surface is in the bacterial adhesion inhibitory performance.
The evaluation results are shown in Table 1.
本発明によれば、バインダー成分を使用することなく歯面に対して微生物付着抑制剤を付着させることができると共に、優れた微生物付着抑制性能を有する歯面用の微生物付着抑制剤を提供することができる。 According to the present invention, it is possible to provide a microbial adhesion inhibitor for a tooth surface, which can adhere a microbial adhesion inhibitor to the tooth surface without using a binder component and has excellent microbial adhesion inhibitory performance. Can be done.
Claims (4)
(一般式(1)において、R1は水素原子又はメチル基を表し、nは1〜4の整数を表す。)
(一般式(2)において、R2は水素原子又はメチル基を表し、L1は、−(C=O)−O−を表し、L2は炭素数12〜18のアルキル基を表す。) It contains a copolymer having a structural unit represented by the following general formula (1) and a structural unit represented by the following general formula (2), and the content of the copolymer is 0.003% by mass or more and 1 mass. % Or less for tooth surface S. Mutant adhesion inhibitor.
(In the general formula (1), R 1 represents a hydrogen atom or a methyl group, and n represents an integer of 1 to 4).
(In the general formula (2), R 2 represents a hydrogen atom or a methyl group, L 1 represents − (C = O) −O−, and L 2 represents an alkyl group having 12 to 18 carbon atoms.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017249194A JP6988463B2 (en) | 2017-12-26 | 2017-12-26 | Microbial adhesion inhibitor for tooth surface |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017249194A JP6988463B2 (en) | 2017-12-26 | 2017-12-26 | Microbial adhesion inhibitor for tooth surface |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019112371A JP2019112371A (en) | 2019-07-11 |
JP6988463B2 true JP6988463B2 (en) | 2022-01-05 |
Family
ID=67222283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017249194A Active JP6988463B2 (en) | 2017-12-26 | 2017-12-26 | Microbial adhesion inhibitor for tooth surface |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6988463B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6977550B2 (en) * | 2017-12-26 | 2021-12-08 | 日油株式会社 | Microbial adhesion inhibitor |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4706435B2 (en) * | 2005-10-26 | 2011-06-22 | 日油株式会社 | Cosmetics, cosmetic nanoparticles and cosmetic powders |
CN102781998B (en) * | 2010-03-09 | 2016-02-03 | 聚合物华润有限公司 | For the block polymers of polyurethane containing one or more polysiloxane blocks of film |
-
2017
- 2017-12-26 JP JP2017249194A patent/JP6988463B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2019112371A (en) | 2019-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6682872B2 (en) | Oral silica dispersion stabilizer and dentifrice composition containing the same | |
US10092500B2 (en) | Oral care compositions | |
EP4034077A1 (en) | Oral care composition with ammonium alkyl sulfonate or carbonate components for treating caries | |
JP7011407B2 (en) | Oral composition | |
JP6988463B2 (en) | Microbial adhesion inhibitor for tooth surface | |
JP7181688B2 (en) | Biofilm formation preventive agent and oral composition | |
WO2007055372A1 (en) | Composition for oral use | |
JP6988462B2 (en) | Microbial adhesion inhibitor for dental prostheses | |
JP2003048842A (en) | Dental plaque inhibitor | |
EP4129413A1 (en) | Composition for oral cavity | |
JP2738092B2 (en) | Oral composition | |
CN112972274A (en) | Dental desensitizer and preparation method and application thereof | |
JP2009102282A (en) | Toothpaste composition and mouthwash agent composition | |
JP7272214B2 (en) | Dental plaque/stain adhesion inhibitor and oral composition | |
JPH0782126A (en) | Composition for oral cavity | |
EP3801441A1 (en) | Oral hygiene compositions for preventing the formation of oral biofilms and process for preparing the same | |
JP7409759B2 (en) | Oral composition | |
JP6925929B2 (en) | Oral composition | |
JP7594345B2 (en) | Oral Composition | |
WO2008069069A1 (en) | Amide compound and salt thereof, and biofilm formation inhibitor or biofilm remover using the same | |
WO2008050858A1 (en) | Amide compound, salt thereof, and biofilm remover using them | |
JP7048272B2 (en) | Oral composition | |
EP3848016A1 (en) | Oral care composition containing fatty acid components for treating caries | |
EP3848017A1 (en) | Oral care composition containing indole components for treating caries | |
WO2021140437A1 (en) | Anionic alkyl sulphate component for treating caries |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200804 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210803 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210909 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20211102 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20211115 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6988463 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |